会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明公开
    • SITE SELECTIVE ACYLATION
    • MAKE选择性酰化
    • EP1456226A1
    • 2004-09-15
    • EP02783948.9
    • 2002-11-18
    • ModPro AB
    • BALTZER, Lars
    • C07K1/10C07K14/00
    • C07K1/1072
    • Disclosed are novel polypeptides consisting of a four helix bundle formed of two dimerized helix-loop-helix motifs, wherein either both have a sequence according to SEQ. ID. No. 1, SEQ. ID. No. 2, SEQ. ID. No. 3, SEQ. ID. No. 4, SEQ. ID. No. 5 or SEQ. ID. No. 7, or one has a sequences according to SEQ. ID. No. 6, and the other one has a sequence according to SEQ. ID. No. 1, SEQ. ID. No. 2, SEQ. ID. No. 3, SEQ. ID. No. 4, SEQ. ID. No. 5 or SEQ. ID. No. 7. Also disclosed is a method for site-selective acylation of a folded polypeptide or protein based on the use of a four helix bundle formed of two dimerized helix-loop-helix motifs folded in an antiparallel mode, said helix-loop-helix motifs comprising amino acid residues in a heptad repeat pattern a b c d e fgn, wherein all but 1-3 of said amino acid residues in positions a and d are non-polar and wherein said 1-3 amino acid residues in positions a and d that are non-polar, are selected from the group consisting of lysine, ornithine, diaminobutyric acid and homolysine, wherein said amino acid residues in positions a and d form a hydrophobic core, wherein the polypeptide and/or protein to be acylated is placed in an aqueous solution and an acylation agent is added. Furthermore, use of said method is disclosed.
    • 77. 发明公开
    • Antigenic modification of polypeptides
    • Antigenische Modifizierung von Peptiden。
    • EP0213391A2
    • 1987-03-11
    • EP86110378.6
    • 1983-05-20
    • The Ohio State University
    • Stevens, Vernon Cecil
    • A61K39/00A61K39/385A61K37/38C07K17/00
    • C07K1/1075A61K38/00A61K39/00A61K39/0006A61K39/385A61K2039/5555A61K2039/55555A61K2039/55566A61K2039/6012A61K2039/627A61K2039/64C07K1/1072C07K1/1077C07K14/59Y10S530/806Y10S930/11
    • Modified polypeptides capable of provoking the formation of antibodies in an animal may be produced by forming a linear polymer of polypeptide fragments, each having a molecular structure similar to a fragment of the protein to which antibodies are to be provoked. Such linear polymers can be made more immunogenic than the proteins to which they are related without introducing undesirable extraneous materials into the animal being treated, but have reproduc- able immunogenic properties. Protein which are not endogenous or immunogenic to an animal can be chemically modified so as to make them more immunogenic. Also, modified antigens useful for fertility control can be produced by chemical modification of zona pellucida or sperm antigens. These modified polypeptides. antigens and modified antigens are desirably administered in the form of a vaccine having a vehicle comprising a mixture of mannide monooleate with Squalene and/or Squalene.
    • 能够诱发动物形成抗体的修饰的多肽可以通过形成多肽片段的线性聚合物来生产,每个片段具有类似于要引发抗体的蛋白质片段的分子结构。 这样的线性聚合物可以比它们相关的蛋白质更具免疫原性,而不会将不需要的外来材料引入被治疗的动物中,但具有可再现的免疫原性。 对动物不是内源性或免疫原性的蛋白质可以进行化学修饰,以使其更具免疫原性。 此外,可以通过化学修饰透明带或精子抗原来产生用于生育控制的修饰抗原。 这些修饰的多肽,抗原和修饰的抗原理想地以具有载体的疫苗形式施用,所述载体包含甘露苷单油酸酯与角鲨烯和/或角鲨烯的混合物。